Chronic Pain

Vanderbilt researchers have identified and characterized inhibitors of an enzyme that synthesizes lipid signaling molecules with roles in energy balance, inflammation and addiction. Read More

This is not the Jedi you're thinking of. This Jedi is a receptor that helps clear away dead neurons during development, and its loss changes the activity of dorsal root ganglia neurons, which could have implications for treating chronic pain. Read More

Kristin Archer, PhD, DPT, associate professor and vice chair of Orthopaedics and Rehabilitation, will serve as principal investigator at Vanderbilt University Medical Center (VUMC) for a clinical trial that is examining strategies for reducing opioid use among patients with chronic pain. Read More

EMPOWER is now enrolling faculty and staff who have insurance coverage through Vanderbilt and are dealing with chronic pain. Read More

Vanderbilt researchers have discovered that variation in the gene encoding the potassium channel GIRK1 plays a role in modulating human pain perception. Read More

Patients with chronic pain who are covered by the Vanderbilt Employee Health Care Plan or workers’ compensation system can now enroll in an innovative rehabilitation program that could dramatically change how chronic pain is treated. Read More

The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics. Read More